Various studies have demonstrated the antithrombotic effect of high dose acetylsalicylic acid (ASA) and more reports show the similar efficiency of the much better tolerated low dose ASA. Recently, in vitro studies hinted the potent thrombotic properties of ultra-low-dose ASA (ULD-ASA, < 1 mg/day) showing a significant decrease in bleeding time( 1,2). This effect was, at least in part, related to the inhibition of endothelial cyclooxygenase -and not to platelet oneleading to a decrease of prostacyclm release (3). To investigate the effect of ASA in vivo, we used an intravital microscopic technique, allowing to evaluate (anti)-thromboembolic events at previously determined locations of the microvasculature. Thrombus formation was induced by Argon-laser shot. The instrumental test set-up was completed with a video-system. The kinetic feature of thrombus formation was estimated in terms of number of laser shots required to induce endothelium injury leading to thrombosis, number of emboli removed by blood stream and duration of embolization. The reliability and reproductibility of our laser-induced thrombus model have been previously tested in rat mesenteric arterioles and veinules and we showed that ASA used at current doses (50-200 mgkg) decreased the number of emboli and the duration of embolization (4). The aim of this preliminary study was the investigation of the effects of ULD-ASA in vivo. In so doing, we evaluated ULD-ASA in our experimental laser-induced thrombus model. This might represent a further step in the understanding of the action of ASA according to the range of concentration used.
Read full abstract